title: [Nocardia farcinica lung infection in a patient with cystic fibrosis and a lung transplant].
abstract: Patients with cystic fibrosis have a higher risk of developing chronic respiratory infectious diseases. The Nocardia farcinica lung infection is rare in this group of patients, and there are limited publications about this topic. Its diagnosis is complex, due to the clinical and the radiology signs being non-specific. Identification of the agent responsible in the sputum culture is occasionally negative. It is a slow growing organism and for this reason treatment is delayed, which can lead to an increase in complications, hospitable stays, and mortality. A case is reported on a 26 year-old woman with cystic fibrosis and chronic lung colonization by Nocardia farcinica and Aspergillus fumigatus, on long-term treatment with ciprofloxacin, trimethoprim-sulfamethoxazole, and posaconazole, who was admitted to ICU after bilateral lung transplantation. The initial post-operative progress was satisfactory. After discharge, the patient showed a gradual respiratory insufficiency with new chest X-ray showing diffuse infiltrates. Initially, the agent was not seen in the sputum culture. Prompt and aggressive measures were taken, due to the high clinical suspicion of a Nocardia farcinica lung infection. Treatment with a combination of amikacin and meropenem, and later combined with linezolid, led to the disappearance of the lung infiltrates and a clinical improvement. In our case, we confirm the rapid introduction of Nocardia farcinica in the new lungs. The complex identification and the delay in treatment increased the morbimortality. There is a special need for its eradication in patients with lung transplant, due to the strong immunosuppressive treatment.
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital La Fe, Valencia, España. Electronic address: carloschacon24@hotmail.com.
authors.forename: C F
authors.initials: CF
authors.lastname: Chacón
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital La Fe, Valencia, España.
authors.forename: R
authors.initials: R
authors.lastname: Vicente
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital La Fe, Valencia, España.
authors.forename: F
authors.initials: F
authors.lastname: Ramos
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital La Fe, Valencia, España.
authors.forename: J
authors.initials: J
authors.lastname: Porta
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital La Fe, Valencia, España.
authors.forename: A
authors.initials: A
authors.lastname: Lopez Maldonado
authors.affiliation: Servicio de Neumología, Hospital La Fe, Valencia, España.
authors.forename: E
authors.initials: E
authors.lastname: Ansotegui
mesh_terms: D000328:Adult; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000453:epidemiology*; D016040:Lung Transplantation; D009617:Nocardia Infections / Q000209:etiology*; D011183:Postoperative Complications / Q000209:etiology*
keywords: Complicación respiratoria; Cystic fibrosis; Fibrosis quística; Infección posoperatoria; Lung transplant; Nocardia farcinica; Organismo resistente; Post-operative infection; Resistant organism; Respiratory complication; Trasplante pulmonar